The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD

N. Karoli, A. Rebrov (Russian Federation)

Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Session: COPD: cardiovascular comorbidities
Session type: E-Communication Session
Number: 5206
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Karoli, A. Rebrov (Russian Federation). The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 5206

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013


Impact of COPD in patients with coronary heart disease submitted to coronary heart bypass graft
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014


Underappreciation of coronary artery disease in patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020




Respiratory, cardiovascular and systemic factors associated with brain damage in Chronic Obstructive Pulmonary Disease (COPD) and/or coronary artery disease (CAD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Comparison of cardiopulmonary exercise test in COPD patients with and without coronary artery disease
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013

Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016

Lipid profile in COPD patients with coronary artery disease comorbidity
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Coronary artery disease risk score calculation and evaluation of statin and antithrombotic drug use among patients admitted with an acute exacarbation of COPD
Source: Annual Congress 2008 - Issues in the management of COPD in the community
Year: 2008

Coronary artery calcification in COPD is associated with adverse functional assessments and mortality
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021


Assessment of pulmonary function stratifies global coronary heart disease risk
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

Dyspnea in patients with coronary artery disease: is it related with physiologic measurements?
Source: Eur Respir J 2001; 18: Suppl. 33, 300s
Year: 2001

Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients
Source: ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020
Year: 2020



Carotid atherosclerosis in COPD patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Endothelial function in COPD vs coronary artery disease and healthy controls: An exploratory study
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016

Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Chronic obstructive pulmonary disease (COPD) exacerbations and carotid artery plaques: The Rotterdam study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013